Respiratory illness updates and health care economics - Insights
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology...
CPT codes and LOINC update: September 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of September.
Artificial intelligence paves way for earlier detection of gastrointestinal cancers - Insights
Mayo Clinic researchers are now using artificial intelligence (AI) systems to help increase polyp detection during colonoscopies and identify colorectal cancer at an early stage. Like facial recognition software that recognizes faces, this...
Elitza Theel, Ph.D., Featured in the Star Tribune - Insights
Dr. Theel, director, Mayo Clinic Infectious Diseases Serology Laboratory, was recently highlighted in the Star Tribune's special issue featuring heroes of the pandemic.
CPT codes and LOINC update: July 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of July.
CPT codes and LOINC update: June 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of June.
CPT codes and LOINC update: October 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of October.
Identifying disease biomarkers with phage immunoprecipitation sequencing - Insights
Mayo Clinic’s Advanced Diagnostics Laboratory researchers are using phage immunoprecipitation sequencing to discover new serological biomarkers for autoimmune diseases.
Ethanol biomarker test features longer detection window - Insights
Mayo Clinic Laboratories has developed a new direct ethanol biomarker test for alcohol consumption that has a much longer detection window than existing urine tests for alcohol use.
Noninvasive DNA testing via liquid biopsy - Insights
The MayoComplete Liquid Biopsy Panel offers a noninvasive alternative to traditional cell-based biopsies. This allow for faster turnaround time and the ability to perform molecular DNA testing in cancer patients where tumor tissue isn’t...